mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.1 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |